Publications by authors named "B Scarpa"
Background: Nasal obstruction is a frequent problem amongst patients with sleep-disordered breathing (SDB). Radiofrequency of the inferior turbinates (RFIT) is commonly utilized for inferior turbinate (IT) reduction but its effectiveness in SDB patients remains unproven. We aim to evaluate long-term objective and subjective nasal, olfactory and sleep outcomes following RFIT in SDB patients.
View Article and Find Full Text PDFChronic rhinosinusitis with nasal polyps (CRSwNP) in the severe forms is associated with a poor quality of life. Dupilumab has been suggested as an add-on treatment option for severe CRSwNP. Severe CRSwNP patients treated with Dupilumab in different rhinological units were considered for this study via their evaluation at the baseline at first and the consequential follow-up at 6-, 12-, and 24 months from the first administration.
View Article and Find Full Text PDFArticle Synopsis
- * A study aimed to investigate if patients with a history of myocarditis would experience relapses during the pandemic or after vaccination.
- * Out of 409 patients studied, none experienced myocarditis relapse due to COVID-19 infection or vaccination, and the rate of new myocarditis cases remained unchanged compared to before the pandemic.
Clinical factors influencing olfactory performance in patients with persistent COVID-19 smell loss longer than 1 year.
Laryngoscope Investig Otolaryngol
December 2023
Objectives: Factors affecting persistence of COVID-19-related olfactory dysfunction (OD) remain partially unknown. We aim to evaluate the clinical factors which could influence olfactory performance in patients with persistent COVID-19-related smell loss.
Methods: A retrospective analysis of 100 patients with persistent COVID-19-related OD was performed between October 2020 and December 2022 at a single-center long-COVID smell clinic.
Objective: In this multicentric study involving three London hospitals, we compared ANCA-positive and ANCA-negative cocaine-induced midline destructive lesions (CIMDL) patients to assess how presence of antineutrophil cytoplasmic antibodies (ANCA) may correlate with disease severity. Our secondary aims are to better classify etiology centered around ANCA positivity and, consequently, better disease management.
Methods: A retrospective review was performed to identify patients with CIMDL seen between January 2019 and December 2022.